Did you know?

The MPS I Registry program, sponsored and administered by Sanofi Genzyme, is a worldwide database that tracks health-related information for people with MPS I, allowing doctors and health care professionals to understand the disorder.

Find Out More
Healthcare Header

“With patients and their families, I continue learning over and over what are the important things in life and which are the ones that are worthy to fight for: life, dignity and hope.”
– Dr. Muñoz, MD

Health Care Professionals

  • Genetics and MPS I

    MPS I is seen in all populations at a frequency of approximately 1:100,000.[1] There are severe and attenuated forms, (historically known as Hurler, Hurler-Scheie, and Scheie) that occur in roughly equal proportions.

    Learn more about MPS I Disease
  • Identifying MPS I

    When a child or young adult presents with joint pain and stiffness but does not demonstrate morning stiffness or local inflammation around the affected joints, MPS I should be considered part of a differential diagnostic process along with Juvenile Idiopathic Arthritis .

    Diagnose MPS I Disease